Abiopharma

Clinical trial NCT07371468: enrollment: 54 → 44 participants.

Clinical trial NCT05952674 updates: 1. start date: 2024-09-19 → 2024-02-19 2. completion date: 2030-08-19 → 2033-02-19 3. primary completion date: 2028-08-26 → 2031-02-26

Clinical trial NCT04854070 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-03-30 → 2025-08-25 3. primary completion date: 2024-07-17 → 2025-08-25

Clinical trial NCT06972303: start date: 2026-02-01 → 2026-03-31.

Clinical trial NCT04669288 updates: 1. start date: 2021-09-22 → 2021-11-22 2. collaborators added: University of Texas Southwestern Medical Center

Clinical trial NCT06076837 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2026-12-01 → 2025-12-22 3. primary completion date: 2026-06-01 → 2025-12-22

Clinical trial NCT05285891 updates: 1. collaborators added: Autoimmunity Centers of Excellence 2. collaborators removed: Autoimmunity Centers of Excellence (ACE)

Clinical trial NCT07061535 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-08-01 → 2025-07-30

Clinical trial NCT04318938 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-30 → 2026-05-30 3. primary completion date: 2026-04-30 → 2026-05-30

Clinical trial NCT05934305 updates: 1. completion date: 2028-06-01 → 2028-06-30 2. primary completion date: 2028-06-01 → 2028-06-30